Form 424B3 NewAmsterdam Pharma Co streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Revitope Oncology Appoints Biotech Industry Pioneer Louis Lange to its Board of Directors
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ Revitope Oncology, Inc., a biotechnology company advancing a new class of precision cancer immunotherapies, today announced the appointment of biotechnology pioneer Louis Lange, M.D., Ph.D., to its Board of Directors. We are pleased to welcome Lou to the Revitope Board of Directors during this unprecedented time at our company as we continue to build upon the tremendous momentum established with our programs, people and partnerships, said Steve Arkinstall, Ph.D., Chief Executive Officer of Revitope Oncology. Lou brings an enormous expertise that spans from disease mechanisms and drug discovery to extensive leadership experience in the biopharmaceutical space, having founded and led numerous biotech companies through critical clinical and regulatory milestones. We re delighted to have hi